Robert Cormack

Robert Cormack is a seasoned professional in regulatory affairs with extensive experience in the biopharmaceutical industry. Currently serving as the Scientific Regulatory Affairs Lead at Capricor Therapeutics, Inc., Robert provides regulatory expertise for cell therapy programs and creates technical content for regulatory documents. Previous roles include Principal Consultant at NDA Group AB and Senior Director of Regulatory Affairs at Capricor Therapeutics, where Robert influenced regulatory strategies for therapies addressing DMD and COVID-19. Robert's career includes significant positions at Pacific-Link Consulting, Amphastar Pharmaceuticals, ICON plc, Sucampo Pharmaceuticals, Human Genome Sciences, and PSI International, contributing expertise in drug development and regulatory processes across various therapeutic areas. Academic credentials include a PhD in Biochemistry from Western University and a BSc in Biochemistry and Biotechnology from Carleton University.